- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 11, 2026 | 3.48M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.31M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 612.89K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $194K |
| Capex | Q1 2026 · Mar 31, 2025 | $0 |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$13.13M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | −$632K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $31.98M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $17.97M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $131K |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $35.1M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $38.88M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | −$4.2M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$2.71M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $25M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $25.99M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $110.28M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $91.52M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $69.8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $53.41M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $145.38M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $130.4M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$3.09 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.21 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$3.09 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.21 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $21.1M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $1.64M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $186K |
| Rd Expense restated | Q1 2026 · Mar 31, 2025 | $194K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$10.24M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | −$1.97M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$13.09M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | −$1.83M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.67M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $0 |
| Revenue | Q1 2026 · Mar 31, 2026 | $10.91M |
| Revenue | Q1 2026 · Mar 31, 2025 | $0 |